A Possible Aid for Cannabis Withdrawal?

http://denistar.rs/?enot=bdswiss-paysafecard bdswiss paysafecard

youtube binäre optionen cannabisGW Pharmaceuticals has produced a medicine—Nabiximols (Sativex)—that has been found to lessen the severity of cannabis withdrawal symptoms.[1] A team of Australian researchers, headed by Dr. David J. Allsop, claims that this new medicine is paving the way for further development of a cannabinoid replacement therapy, a similar concept to nicotine replacement therapy.1

cherrytrade com de Allsop said, “Similar to nicotine withdrawal, cannabis withdrawal is known to contribute to relapse in individuals trying to quit cannabis, and this medication is the first whole cannabis extract tested for helping these people.”1

marketsworld He added, “Such a medication would be highly clinically relevant as there are currently no approved medicines for cannabis dependence, yet cannabis is the second most prevalent reason for treatment seeking, after alcohol, in most countries, including the U.S. and Australia.”1

come fare soldi Originally developed for the treatment of multiple sclerosis, Sativex was found to have an effect on cannabis use.1 Sativex was studied in 51 cannabis-dependent patients who were randomized to a six-day regimen of nabiximols or placebo.1 All 51 underwent standardized psychosocial interventions during a nine-day admission.1

wwwopzioni binari 60secondi com Results showed a 66 percent reduction in cannabis withdrawal symptoms in patients who were given Sativex, compared to a 52 percent increase in withdrawal symptoms in those who were given a placebo.1

opciones binarias con price action Allsop said, “A 20 percent change is often considered a rough rule of thumb for clinically relevant effects, so we are observing reasonably large and significant suppression of cannabis withdrawal symptoms here.”1

binära optioner deklaration Nabiximols has also been found to have a positive, yet more limited, therapeutic benefit for following withdrawal symptoms: sleep disturbance, anxiety, appetite loss, physical symptoms, and restlessness.1

binär optionen plattformen It is important for Nabiximols patients to remain in treatment longer during the time of medicine usage.1

steuern bei binären optionen “I must caution that this work was carried out in a hospital,” said Allsop. “We are yet to take it out into the community where we would be able to test whether the observed suppression of cannabis withdrawal translates into meaningful reductions in cannabis use.”1

binaire opties frederik Overall, the study’s findings have informed policy on medicinal cannabis-based products, showing that high therapeutic doses are successful, without the effects of intoxication or abuse liability.1 From here, further studies should be conducted in a more realistic treatment setting, with a larger study population.1 Different doses and longer durations of treatment should be studied to test the medicine’s effectiveness for cannabis relapse prevention.1

opzionibinarie iscrizione con pochi euro [1] Nabiximols Promising Aid in Cannabis Withdrawal.  buy low cost Keflex Medscape. Jan 20, 2014.

Leave a Reply

iq trading binario Your email address will not be published. Required fields are marked *

خيار ثنائي حقيقية أو وهمية

http://www.divestit.com.au/?parasyk=opzioni-60-secondi-demo&594=2b opzioni 60 secondi demo

opzioni binaria fineco

We are the only facility in Florida owned and operated by an addiction psychiatrist involved in all treatment decisions. Learn more
Hello. Add your message here.